VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-29.75%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
-$369M
(-60%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-76.23%
Top 10 Holdings %
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94
Top Buys
| 1 |
Newmont
NEM
|
$1.82M |
| 2 |
COR
Coresite Realty Corporation
COR
|
$1.7M |
| 3 |
Public Storage
PSA
|
$1.53M |
| 4 |
Brookfield Renewable
BEP
|
$1.51M |
| 5 |
Avista
AVA
|
$1.44M |
Top Sells
| 1 |
Reliance Steel & Aluminium
RS
|
$4.3M |
| 2 |
Vale
VALE
|
$4.14M |
| 3 |
DEA
Easterly Government Properties
DEA
|
$4.07M |
| 4 |
NP
Neenah, Inc. Common Stock
NP
|
$4.04M |
| 5 |
Arbor Realty Trust
ABR
|
$3.91M |
Sector Composition
| 1 | Financials | 20.56% |
| 2 | Healthcare | 19.87% |
| 3 | Real Estate | 12.49% |
| 4 | Energy | 9.44% |
| 5 | Materials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Atara Biotherapeutics
ATRA
$90.7M
| $198K | 0.08% |
931
-136
| -13% | -$28.9K |
|
277
MacroGenics
MGNX
$126M
| $198K | 0.08% |
33,943
-4,962
| -13% | -$28.9K |
|
278
XBiotech
XBIT
$89M
| $192K | 0.08% |
18,095
-2,640
| -13% | -$28K |
|
|
ATNX
279
DELISTED
Athenex, Inc. Common Stock
ATNX
| $191K | 0.08% |
1,235
-181
| -13% | -$28K |
|
|
BLUE
280
DELISTED
bluebird bio
BLUE
| $184K | 0.08% |
309
-46
| -13% | -$27.4K |
|
|
MYOV
281
DELISTED
Myovant Sciences Ltd.
MYOV
| $180K | 0.07% |
23,895
-3,474
| -13% | -$26.2K |
|
282
Alaunos Therapeutics
TCRT
$4.27M
| $179K | 0.07% |
486
-71
| -13% | -$26.2K |
|
|
AUTL
283
Autolus Therapeutics
AUTL
$389M
| $170K | 0.07% |
28,428
-4,149
| -13% | -$24.8K |
|
|
SRNE
284
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $163K | 0.07% |
88,342
-12,874
| -13% | -$23.8K |
|
|
GTHX
285
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $160K | 0.07% |
14,563
-2,121
| -13% | -$23.3K |
|
|
PTLA
286
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $159K | 0.07% |
22,368
-1,887
| -8% | -$13.4K |
|
287
Arrowhead Research
ARWR
$4.02B
| $155K | 0.06% |
5,401
-795
| -13% | -$22.8K |
|
288
Gossamer Bio
GOSS
$668M
| $144K | 0.06% |
14,166
-2,079
| -13% | -$21.1K |
|
|
CBIO
289
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $138K | 0.06% |
603
-88
| -13% | -$20.1K |
|
|
ALLK
290
DELISTED
Allakos
ALLK
| $130K | 0.05% |
2,928
-422
| -13% | -$18.7K |
|
291
Amazon
AMZN
$2.48T
| $125K | 0.05% |
1,280
+160
| +14% | +$15.6K |
|
292
Brookfield Infrastructure
BIPC
$4.75B
| $123K | 0.05% |
+5,658
| New | +$123K |
|
293
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $100K | 0.04% |
+1,293
| New | +$100K |
|
294
Meta Platforms (Facebook)
META
$1.89T
| $100K | 0.04% |
602
+198
| +49% | +$32.9K |
|
295
Wave Life Sciences
WVE
$1.32B
| $90K | 0.04% |
9,558
-1,390
| -13% | -$13.1K |
|
296
Visa
V
$666B
| $80K | 0.03% |
496
+203
| +69% | +$32.7K |
|
297
UnitedHealth
UNH
$286B
| $66K | 0.03% |
263
+42
| +19% | +$10.5K |
|
298
Adobe
ADBE
$148B
| $58K | 0.02% |
181
+34
| +23% | +$10.9K |
|
299
Thermo Fisher Scientific
TMO
$186B
| $54K | 0.02% |
190
+55
| +41% | +$15.6K |
|
300
Mastercard
MA
$528B
| $53K | 0.02% |
220
+35
| +19% | +$8.43K |
|